MedicaidPrior AuthMedium impact
MAB2025110704
Pennsylvania Medicaid (DHS)·PA · Hematology, Pharmacy·Provider Bulletin
Effective date
Jan 5, 2026
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid is implementing new prior authorization requirements for antihemophilia agents (blood clotting factors) effective January 5, 2026. All antihemophilia prescriptions will require prior auth with specific medical necessity criteria, including prescriber requirements (hematologist or hemophilia treatment center) and diagnosis-specific guidelines.
Action Required
Before January 5, 2026: Billing and clinical teams must implement prior authorization processes for all antihemophilia agents for Pennsylvania Medicaid patients. Ensure prescriptions are from hematologists or hemophilia treatment centers, document FDA-approved indications and dosing, and verify preferred drug list compliance at https://papdl.com/preferred-drug-list. Update pharmacy billing systems to trigger prior auth requirements. Claims without proper prior authorization will be denied.